Search

Your search keyword '"Wermker, Kai"' showing total 135 results

Search Constraints

Start Over You searched for: Author "Wermker, Kai" Remove constraint Author: "Wermker, Kai"
135 results on '"Wermker, Kai"'

Search Results

5. German S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” – Long version of the update 2023

12. S3‐Leitlinie “Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Update 2023, Teil 2: Epidemiologie und Ätiologie, Diagnostik, Therapie des invasiven Plattenepithelkarzinoms der Haut, Nachsorge und Prävention

13. S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention

15. S3‐Leitlinie “Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Update 2023, Teil 1: Therapie der aktinischen Keratose, Morbus Bowen, Cheilitis actinica, berufsbedingte Erkrankung und Versorgungsstrukturen

16. S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“– update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care

22. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) – short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow‐up, prevention and occupational disease

23. S3‐Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Kurzfassung, Teil 2: Epidemiologie, chirurgische und systemische Therapie des Plattenepithelkarzinoms, Nachsorge, Prävention und Berufskrankheit

24. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma – short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality‐of‐care indicators

25. S3‐Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Kurzfassung, Teil 1: Diagnostik, Interventionen bei aktinischen Keratosen, Versorgungsstrukturen und Qualitätsindikatoren

26. Short time administration of antirheumatic drugs - Methotrexate as a strong inhibitor of osteoblast's proliferation in vitro

28. Sphenopalatine Ganglion Stimulation to Augment Cerebral Blood Flow

29. The impact of hyperbaric oxygen therapy on serological values of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF)

30. Release kinetics of VEGF165 from a collagen matrix and structural matrix changes in a circulation model

31. Dental Implants in Cleft Lip, Alveolus, and Palate Patients: A Systematic Review.

32. Hauttumore der Lidregion: Rekonstruktive Verfahren und Ergebnisse

33. Cutaneous SCC and oral SCC - dual immunosuppression via expression of FOXP3 in tumour cells and through recruitment of FOXP3+ regulatory T-cells

35. Short time administration of antirheumatic drugs - Methotrexate as a strong inhibitor of osteoblast´s proliferation in vitro

49. Release kinetics of VEGF165 from a collagen matrixand structural matrix changes in a circulationmodel.

50. S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention.

Catalog

Books, media, physical & digital resources